Global next generation cancer diagnostics market is expected to grow with a healthy CAGR over the forecast period from 2020-2026

The report on the global next generation cancer diagnostics market provides qualitative and quantitative analysis for the period from 2018 to 2026. The report predicts the global next generation cancer diagnostics market to grow with a healthy CAGR over the forecast period from 2020-2026.

New York, Aug. 28, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Next Generation Cancer Diagnostics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" - https://www.reportlinker.com/p05954453/?utm_source=GNW
The study on next generation cancer diagnostics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2018 to 2026.

The report on next generation cancer diagnostics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global next generation cancer diagnostics market over the period of 2018 to 2026. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global next generation cancer diagnostics market over the period of 2018 to 2026. Further, IGR-Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
• The increasing number of research projects on oncology because of the increasing prevalence of oncological disorders across the world
• Government measures are taken by developed and developing nations to upsurge the number of research projects in accordance with oncology and preventative diagnosis
2) Restraints
• The inadequate reimbursement policies for innovative technologies and the strict regulatory procedures
3) Opportunities
• The mounting development of advanced next-generation cancer diagnostic technologies

Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global next generation cancer diagnostics market is segmented on the basis of technology, application, cancer type, and function.

Global Next Generation Cancer Diagnostics Market by Technology
• QPCR and Multiplexing
• Benchtop Sequencers
• Lab-on-a-chip
• Next Generation Sequencing
• Protein Microarrays
• DNA Microarrays
• Other

Global Next Generation Cancer Diagnostics Market by Application
• Biomarker Development
• Proteomic Analysis
• CTC Analysis
• Genetic Analysis
• Epigenetic Analysis

Global Next Generation Cancer Diagnostics Market by Cancer Type
• Lung Cancer
• Colorectal Cancer
• Breast Cancer
• Prostate Cancer
• Others

Global Next Generation Cancer Diagnostics Market by Function
• Cancer Screening
• Therapeutic Monitoring
• Prognosis Diagnostics
• Risk Analysis
• Companion Diagnostics

Company Profiles
• Cepheid
• Koninklijke Philips N.V.
• F. Hoffmann-La Roche Ltd
• Qiagen
• Novartis AG
• Abbott Laboratories
• Thermo Fisher Scientific, Inc.
• Opko Health, Inc.
• Myriad Genetics, Inc.
• Agilent Technologies

What Does This Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the next generation cancer diagnostics market.
2. Complete coverage of all the segments in the next generation cancer diagnostics market to analyze the trends, developments in the global market and forecast of market size up to 2026.
3. Comprehensive analysis of the companies operating in the global next generation cancer diagnostics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR-Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Read the full report: https://www.reportlinker.com/p05954453/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001